š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This phase ā ” clinical study was designed to evaluate the immunogenicity and...
Status
Unknown
Location
Multiple Locations
Start Date
2016-03-24
Trial ID
NCT02710851
This is a phase II randomized, observer-blinded, placebo-controlled study w...
Status
Recruiting
Location
The Aga Khan University
Start Date
2024-05-02
Trial ID
NCT05808166
This is a Phase III clinical trial of the novel recombinant HPV 16/18 bival...
Status
Completed
Location
Cancer Institute ļ¼ Hospital Chinese Academy of Medical Sciences
Start Date
2012-11-22
Trial ID
NCT01735006
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of c...
Status
Unknown
Location
Zhejiang Provincial Center for Disease Control and Prevention
Start Date
2021-10-25
Trial ID
NCT05415345
This study is to evaluate lot-lot consistency of Recombinant Hepatitis E Va...
Status
Completed
Location
Dongtai City Center for Disease Control and Prevention
Start Date
2018-10-27
Trial ID
NCT03365921
The primary goal of this clinical trial is to demonstrate non-inferiority o...
Status
Recruiting
Location
MeCRU Clinical Research Unit
Start Date
2024-04-04
Trial ID
NCT06306196
Treatments Being Tested
The aim of the study is to determine the effectiveness of hepatitis E virus...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2017-10-02
Trial ID
NCT02759991
This phase IV clinical study was designed to evaluate the safety and immuno...
Status
Completed
Location
Kaihua Center for Disease Control and Prevention
Start Date
2015-04
Trial ID
NCT02417597
Treatments Being Tested
This phase IV clinical study was designed to evaluate the immunogenicity an...
Status
Completed
Location
Rushan Center for Disease Control and Prevention
Start Date
2016-08
Trial ID
NCT02964910
Treatments Being Tested
This phase IV clinical study was designed to evaluate the immunogenicity an...
Status
Completed
Location
Changshan Center for Disease Control and Prevention
Start Date
2017-05-25
Trial ID
NCT03168412